MAPK/NF-ĸB/STAT3 Signaling Axes Were Inactivated Upon DCHT Treatment in the Setting of Intrahepatic Cholestasis With Liver Injury in Response to ANIT. Here, STK39 is linked to intrahepatic cholestasis.